Cellistic
Stefan Braam is a President and CTO at Ncardia and also serves as the President and CTO at Cellistic. Previously, Stefan was the CEO at Pluriomics, where Stefan was responsible for technology development, R&D, and business development. Stefan has a strong background in stem cell research and has held various research and leadership positions in the field. Stefan is actively involved in strategy and business development in the companies Stefan has worked for.
This person is not in any offices
Cellistic
Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com.